Docosahexaenoic acid and angiogenesis: a role in early placentation

Bibliography

• Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8(6), 464–478 (2007)
   Google Scholar
• Albrecht ED, Pepe GJ. Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy. Int. J. Dev. Biol. 54(2–3), 397–408 (2010)
   Google Scholar
• Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 146(6), 873–887 (2011)
   Google Scholar
• Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, Corvera S. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am. J. Physiol. Endocrinol. Metab. 295(5), e1056–e1064 (2008)
   Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 235(4787), 442–447 (1987)
   Google Scholar
• Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. Suppl. 77, S113–S119 (2000)
   Google Scholar
• Sterescu AE, Rousseau-Harsany E, Farrell C, Powell J, David M, Dubois J. The potential efficacy of omega?3 fatty acids as antiangiogenic agents in benign vascular tumors of infancy. Med. Hypotheses 66(6), 1121–1124 (2006). n The authors hypothesize that n?3 fatty acids may be used as an adjuvant treatment for hemangiomas by slowing down their rapid proliferation phase through antiangiogenic and antitumoral effects. n?3 fatty acids are thought to downregulate VEGF and bFGF expression and suppress proangiogenic eicosanoids, such as COX2
   Google Scholar
• Sapieha P, Stahl A, Chen J et al. 5-lipoxygenase metabolite 4?HDHA is a mediator of the antiangiogenic effect of omega?3 polyunsaturated fatty acids. Sci. Transl Med. 3(69), 69ra12 (2011)
   Google Scholar
• Dutta-Roy AK. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am. J. Clin. Nutr. 71(Suppl. 1), S315–S322 (2000)
   Google Scholar
• Johnsen GM, Basak S, Weedon-Fekjaer MS, Staff AC, Duttaroy AK. Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. Placenta 32(9), 626–632 (2011). nn Docosahexaenoic acid may potently influence the early placentation process by stimulating tube formation and this effect may be mediated in part via VEGF in first-trimester trophoblast cells
   Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13(1), 9–22 (1999)
   Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18(1), 4–25 (1997)
   Google Scholar
• Yang SP, Morita I, Murota SI. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk?1 receptor expression in bovine carotid artery endothelial cells. J. Cell. Physiol. 176(2), 342–349 (1998). n Highlights the antitumor effect of eicosapentaenoic acid related to antiangiogenic action. Eicosapentaenoic acid selectively inhibited VEGF-induced, but not bFGF?induced, activation of MAPK
   Google Scholar
• Aiello LP, Bursell SE, Clermont A et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46(9), 1473–1480 (1997)
   Google Scholar
• Charnock-Jones DS, Sharkey AM, Rajput- Williams J et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48(5), 1120–1128 (1993)
   Google Scholar
• Charnock-Jones DS, Sharkey AM, Boocock CA et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod. 51(3), 524–530 (1994)
   Google Scholar
• Torry DS, Torry RJ. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reprod. Immunol. 37(1), 21–29 (1997)
   Google Scholar
• Fairbrother WJ, Christinger HW, Cochran AG et al. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry 37(51), 17754–17764 (1998)
   Google Scholar
• Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6(5), 637–648 (1998)
   Google Scholar
• Brouillet S, Hoffmann P, Chauvet S et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG?VEGF and its receptors. Cell. Mol. Life Sci. 69(9), 1537–1550 (2011)
   Google Scholar
• Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor?2: structure, function, intracellular signalling and therapeutic inhibition. Cell. Signal. 19(10), 2003–2012 (2007)
   Google Scholar
• Jones D, Xu Z, Zhang H et al. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Arterioscler. Thromb. Vasc. Biol. 30(12), 2553–2561 (2010)
   Google Scholar
• Cao R, Xue Y, Hedlund EM et al. VEGFR1?mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc. Natl Acad. Sci. USA 107(2), 856–861 (2010)
   Google Scholar
• Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal. 2(59), re1 (2009)
   Google Scholar
• Chaballe L, Schoenen J, Franzen R. Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology? Acta Neurol. Belg. 111(1), 10–17 (2011)
   Google Scholar
• Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol. Reprod. 64(4), 1033–1040 (2001)
   Google Scholar
• Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111(5), 649–658 (2003). n Demonstrates that placental soluble Flt-1, an antagonist of VEGF and PlGF, is upregulated in pre-eclampsia, leading to increased systemic levels of soluble Flt-1. It also demonstrates that an increased level of circulating soluble Flt-1 in patients with pre?eclampsia is associated with decreased circulating levels of free VEGF and PlGF, resulting in endothelial dysfunction in vitro that can be rescued by exogenous VEGF and PlGF
   Google Scholar
• Mandard S, Zandbergen F, Tan NS et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279(33), 34411–34420 (2004)
   Google Scholar
• Kersten S, Mandard S, Tan NS et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275(37), 28488–28493 (2000)
   Google Scholar
• Lee JH, Seo JM, Kim M, Kim JC. Cloning of cDNA for a novel fibrinogen/angiopoietinrelated protein, FARP. Mol. Cells 11(1), 100–104 (2001)
   Google Scholar
• Gonzalez-Muniesa P, de Oliveira C, Perez de Heredia F, Thompson MP, Trayhurn P. Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/fasting-induced adipose factor) by human adipocytes. J. Nutrigenet. Nutrigenomics 4(3), 146–153 (2011). n Showed that ANGPTL4 is regulated by both hypoxia and fatty acids in human adipocytes. The stimulatory effect of fatty acids on ANGPTL4 production is improved under hypoxic conditions
   Google Scholar
• Murata M, Yudo K, Nakamura H et al. Hypoxia upregulates the expression of angiopoietin-like-4 in human articular chondrocytes: role of angiopoietin-like-4 in the expression of matrix metalloproteinases and cartilage degradation. J. Orthop. Res. 27(1), 50–57 (2009)
   Google Scholar
• Hermann LM, Pinkerton M, Jennings K et al. Angiopoietin-like?4 is a potential angiogenic mediator in arthritis. Clin. Immunol. 115(1), 93–101 (2005)
   Google Scholar
• Mandard S, Zandbergen F, van Straten E et al. The fasting-induced adipose factor/ angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281(2), 934–944 (2006)
   Google Scholar
• Zhang H, Wong CC, Wei H et al. HIF?1?dependent expression of angiopoietin?like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31(14), 1757–1770 (2011)
   Google Scholar
• Chomel C, Cazes A, Faye C et al. Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietinlike 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 23(3), 940–949 (2009)
   Google Scholar
• Goh YY, Pal M, Chong HC et al. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J. Biol. Chem. 285(43), 32999–33009 (2010). n The authors' findings provide molecular insight into a novel control of wound healing via ANGPTL4-dependent regulation of cell–matrix communication. Apart from its role in glucose and lipid homeostasis, ANGPT4 is a prime therapeutic candidate for the treatment of diabetic wounds
   Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347), 298–307 (2011)
   Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J. Matern. Fetal Neonatal Med. 24(10), 1187–1207 (2011)
   Google Scholar
• Patel J, Landers K, Mortimer RH, Richard K. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta 31(11), 951–957 (2010). n The authors explore oxygen-dependent and -independent regulation, and the role of hypoxia-inducible factors in placental development and differentiation. In low-oxygen environments, hypoxia-inducible factors are the main regulators in the transcription of a number of genes. The hypoxia-inducible factors can function throughout all stages of placental differentiation and growth, both in normal and pathological pregnancies
   Google Scholar
• Hardman WE. (n?3) fatty acids and cancer therapy. J. Nutr. 134(Suppl. 12), S3427–S3430 (2004)
   Google Scholar
• Murphy RA, Mourtzakis M, Mazurak VC. n?3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Curr. Opin Clin. Nutr. Metab. Care 15(3), 246–251 (2012)
   Google Scholar
• Mozaffarian D, Wu JH. Omega?3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58(20), 2047–2067 (2011)
   Google Scholar
• Vedtofte MS, Jakobsen MU, Lauritzen L, Heitmann BL. Dietary alpha-linolenic acid, linoleic acid, and n?3 long-chain PUFA and risk of ischemic heart disease. Am. J. Clin. Nutr. 94(4), 1097–1103 (2011)
   Google Scholar
• Kim S, Sandler DP, Galanko J, Martin C, Sandler RS. Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am. J. Epidemiol. 171(9), 969–979 (2010)
   Google Scholar
• Spencer L, Mann C, Metcalfe M et al. The effect of omega?3 FAs on tumour angiogenesis and their therapeutic potential. Eur. J. Cancer 45(12), 2077–2086 (2009). nn The authors explore the evidence and mechanisms by which n?3 fatty acids may act as angiogenesis inhibitors. They suggest that n?3 fatty acids, in particular eicosapentaenoic acid and docosahexaenoic acid, have potent antiangiogenic effects inhibiting the production of many important angiogenic factors
   Google Scholar
• Szymczak M, Murray M, Petrovic N. Modulation of angiogenesis by omega?3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 111(7), 3514–3521 (2008)
   Google Scholar
• Takahashi S. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biol. Pharm. Bull. 34(12), 1785–1788 (2011)
   Google Scholar
• Massaro M, Scoditti E, Carluccio MA, Campana MC, De Caterina R. Omega?3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell. Mol. Biol. (Noisy-le-grand) 56(1), 59–82 (2010)
   Google Scholar
• Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Cardiovasc. Res. 86(2), 302–310 (2010)
   Google Scholar
• Kim HJ, Vosseler CA, Weber PC, Erl W. Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J. Cell. Physiol. 204(3), 881–888 (2005)
   Google Scholar
• Murota SI, Onodera M, Morita I. Regulation of angiogenesis by controlling VEGF receptor. Ann. NY Acad. Sci. 902, 208–212; discussion 212–213 (2000)
   Google Scholar
• Kanayasu T, Morita I, Nakao-Hayashi J et al. Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids 26(4), 271–276 (1991)
   Google Scholar
• Ghosh-Choudhury T, Mandal CC, Woodruff K et al. Fish oil targets PTEN to regulate NFkappaB for downregulation of antiapoptotic genes in breast tumor growth. Breast Cancer Res. Treat. 118(1), 213–228 (2009)
   Google Scholar
• Tsuji M, Murota SI, Morita I. Docosapentaenoic acid (22:5, n?3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot. Essent. Fatty Acids 68(5), 337–342 (2003)
   Google Scholar
• Calviello G, Di Nicuolo F, Gragnoli S et al. n?3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK?1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25(12), 2303–2310 (2004)
   Google Scholar
• Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGFmediated angiogenic signaling in microvascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 51(12), 6815–6825 (2010)
   Google Scholar
• Maraldi T, Prata C, Caliceti C et al. VEGF-induced ROS generation from NAD(P)H oxidases protects human leukemic cells from apoptosis. Int. J. Oncol. 36(6), 1581–1589 (2010)
   Google Scholar
• Li Q, Zhang Q, Wang M et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 89(1), 169–177 (2007)
   Google Scholar
• Hamed EA, Zakary MM, Abdelal RM, Abdel Moneim EM. Vasculopathy in Type 2 diabetes mellitus: role of specific angiogenic modulators. J. Physiol. Biochem. 67(3), 339–349 (2011)
   Google Scholar
• Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin. Reprod. Endocrinol. 17(3), 275–290 (1999)
   Google Scholar
• Torry RJ, Rongish BJ. Angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis. Am. J. Reprod. Immunol. 27(3–4), 171–179 (1992)
   Google Scholar
• Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol. 179(6 Pt 1), 1539–1544 (1998)
   Google Scholar
• Kulkarni AV, Mehendale SS, Yadav HR, Joshi SR. Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt?1 in preeclampsia. Prostaglandins Leukot. Essent. Fatty Acids 84(1–2), 51–55 (2011)
   Google Scholar
• Innis SM. Essential fatty acids in growth and development. Prog. Lipid Res. 30(1), 39–103 (1991)
   Google Scholar
• Duttaroy AK. Transport of fatty acids across the human placenta: a review. Prog. Lipid Res. 48(1), 52–61 (2009)
   Google Scholar
• Gottlicher M, Demoz A, Svensson D, Tollet P, Berge RK, Gustafsson JA. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem. Pharmacol. 46(12), 2177–2184 (1993)
   Google Scholar
• Salem N Jr, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36(9), 945–959 (2001)
   Google Scholar
• Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development. Lipids 36(9), 885–895 (2001)
   Google Scholar
• Staiger H, Haas C, Machann J et al. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58(3), 579–589 (2009)
   Google Scholar
• Yamada T, Ozaki N, Kato Y, Miura Y, Oiso Y. Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 347(4), 1138–1144 (2006)
   Google Scholar
• Georgiadi A, Lichtenstein L, Degenhardt T et al. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor b/d and protects against fatty acid-induced oxidative stress. Circ. Res. 106, 1712–1721 (2010).
   Google Scholar